La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Encompass Health Gestione

Gestione criteri di controllo 3/4

Encompass Health's Il CEO è Mark Tarr, nominato in Dec2016, e ha un mandato di 7.67 anni. la retribuzione annua totale è $ 8.84M, composta da 11.9% di stipendio e 88.1% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.55% delle azioni della società, per un valore di € 44.03M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 11 anni e 4.6 anni.

Informazioni chiave

Mark Tarr

Amministratore delegato

US$8.8m

Compenso totale

Percentuale dello stipendio del CEO	11.9%
Mandato del CEO	7.8yrs
Proprietà del CEO	0.6%
Durata media del management	11.1yrs
Durata media del Consiglio di amministrazione	4.7yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Mark Tarr rispetto agli utili di Encompass Health?
Data	Compenso totale	Stipendio	Guadagni aziendali
Jun 30 2024	n/a	n/a	US$409m
Mar 31 2024	n/a	n/a	US$387m
Dec 31 2023	US$9m	US$1m	US$362m
Sep 30 2023	n/a	n/a	US$357m
Jun 30 2023	n/a	n/a	US$336m
Mar 31 2023	n/a	n/a	US$280m
Dec 31 2022	US$8m	US$1m	US$256m
Sep 30 2022	n/a	n/a	US$232m
Jun 30 2022	n/a	n/a	US$242m
Mar 31 2022	n/a	n/a	US$253m
Dec 31 2021	US$8m	US$1m	US$298m
Sep 30 2021	n/a	n/a	US$316m
Jun 30 2021	n/a	n/a	US$318m
Mar 31 2021	n/a	n/a	US$304m
Dec 31 2020	US$7m	US$953k	US$193m
Sep 30 2020	n/a	n/a	US$265m
Jun 30 2020	n/a	n/a	US$285m
Mar 31 2020	n/a	n/a	US$342m
Dec 31 2019	US$7m	US$1m	US$358m
Sep 30 2019	n/a	n/a	US$317m
Jun 30 2019	n/a	n/a	US$308m
Mar 31 2019	n/a	n/a	US$309m
Dec 31 2018	US$6m	US$963k	US$290m
Sep 30 2018	n/a	n/a	US$339m
Jun 30 2018	n/a	n/a	US$316m
Mar 31 2018	n/a	n/a	US$288m
Dec 31 2017	US$5m	US$900k	US$271m

Compensazione vs Mercato: La retribuzione totale di Mark ($USD 8.84M ) è superiore alla media delle aziende di dimensioni simili nel mercato German ($USD 3.48M ).

Compensazione vs guadagni: La retribuzione di Mark è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Mark Tarr (62 yo)

7.8yrs

Mandato

US$8,836,376

Compensazione

Mr. Mark J. Tarr serves as Director at Protective Life Corporation since April 04, 2023. He serves as President, Chief Executive Officer and Director of Encompass Health Corp. since December 29, 2016. He s...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Mark Tarr	CEO, President & Director	7.8yrs	US$8.84m	0.55% $ 47.6m
Douglas Coltharp	Executive VP & CFO	14.3yrs	US$5.75m	0.26% $ 22.5m
Andrew Price	Senior VP & Chief Accounting Officer	14.9yrs	US$1.10m	0.076% $ 6.6m
John Darby	Executive VP	8.6yrs	US$3.17m	0.084% $ 7.3m
Elissa Charbonneau	Chief Medical Officer	9.2yrs	US$1.30m	0.018% $ 1.6m
Rusty Yeager	Chief Information Officer & Senior VP	13.2yrs	Nessun dato	Nessun dato
Mark Miller	Senior Vice President of Investor Relations & Strategic Planning	3yrs	Nessun dato	Nessun dato
Dawn Rock	Chief Compliance Officer	9.2yrs	Nessun dato	Nessun dato
Anthony Hernandez	Chief Human Resources Officer	4.7yrs	Nessun dato	Nessun dato
Frank Brown	President of Southwest Region	13yrs	Nessun dato	Nessun dato
Jerry Gray	President of West Region	13yrs	Nessun dato	Nessun dato
Peter Mantegazza	President of Northeast Region	16.3yrs	Nessun dato	Nessun dato

11.1yrs

Durata media

60.5yo

Età media

Gestione esperta: Il team dirigenziale di HSOA è esperto e expertise (durata media dell'incarico 11 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Mark Tarr	CEO, President & Director	7.8yrs	US$8.84m	0.55% $ 47.6m
Joan Herman	Independent Director	11.7yrs	US$289.80k	0.00099% $ 85.7k
Leslye Katz	Independent Director	11.7yrs	US$294.80k	0.00099% $ 85.7k
Nancy Schlichting	Independent Director	6.8yrs	US$259.79k	0.000040% $ 3.5k
Gregory Carmichael	Independent Chairman	4.7yrs	US$276.01k	0.0038% $ 329.7k
Patricia Maryland	Independent Director	4.7yrs	US$256.01k	0.000020% $ 1.7k
Christopher Reidy	Independent Director	2.9yrs	US$272.98k	0.012% $ 1.0m
Edward Christie	Director	less than a year	US$74.45k	0.00049% $ 42.4k
Kevin O'Connor	Independent Director	2.5yrs	US$252.54k	0.0010% $ 87.4k
Terrance Williams	Independent Director	4.7yrs	US$271.01k	0.00035% $ 30.3k

4.7yrs

Durata media

64.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di HSOA sono considerati esperti (durata media dell'incarico 4.6 anni).

Encompass Health Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Chief Medical Officer recently sold €783k worth of stock

Encompass Health Corporation, Annual General Meeting, May 02, 2024

Encompass Health Corporation Appoints Andrew Baird as Senior Vice President of Public Policy, Legislation and Regulations

Encompass Health Corporation Appoints Edward M. Christie III to Its Board of Directors

Encompass Health Corporation Appoints Edward M. Christie III to Its Board of Directors

Chief Medical Officer recently sold €531k worth of stock

Recent updates

Upcoming dividend of US$0.17 per share

Second quarter 2024 earnings released: EPS: US$1.15 (vs US$0.93 in 2Q 2023)

Encompass Health Corporation Raises Earnings Guidance for Full Year 2024

Dividend of US$0.17 announced

Encompass Health Declares Dividend on Common Stock, Payable on October 15, 2024

Encompass Health Corporation to Report Q2, 2024 Results on Aug 05, 2024

Encompass Health Corporation(NYSE:EHC) dropped from Russell Small Cap Comp Growth Index

Chief Medical Officer recently sold €783k worth of stock

First quarter dividend of US$0.15 announced

Encompass Health Declares Dividend on Common Stock, Payable on July 15, 2024

Encompass Health Corporation Provides Earnings Guidance for 2024

First quarter 2024 earnings released: EPS: US$1.14 (vs US$0.89 in 1Q 2023)

Encompass Health Corporation to Report Q1, 2024 Results on Apr 24, 2024

Encompass Health Corporation, Annual General Meeting, May 02, 2024

Encompass Health Corporation Appoints Andrew Baird as Senior Vice President of Public Policy, Legislation and Regulations

Upcoming dividend of US$0.15 per share

Fourth quarter dividend of US$0.15 announced

Full year 2023 earnings released: EPS: US$3.66 (vs US$2.57 in FY 2022)

Encompass Health Corporation Provides Earnings Guidance for the Year 2024

Encompass Health Corporation to Report Q4, 2023 Results on Feb 07, 2024

Upcoming dividend of US$0.15 per share at 0.9% yield

Encompass Health Corporation Appoints Edward M. Christie III to Its Board of Directors

Encompass Health Corporation Appoints Edward M. Christie III to Its Board of Directors

Encompass Health Corporation Revises Earnings Guidance for the Year 2023

Third quarter 2023 earnings released: EPS: US$0.87 (vs US$0.64 in 3Q 2022)

Encompass Health Corporation to Report Q3, 2023 Results on Oct 26, 2023

Upcoming dividend of US$0.15 per share at 0.9% yield

Chief Medical Officer recently sold €531k worth of stock

Encompass Health Corporation Updates Earnings Guidance for the Full-Year 2023

Encompass Health Corporation Declares Quarterly Cash Dividend, Payable on October 16, 2023

Encompass Health Corporation to Report Q2, 2023 Results on Aug 01, 2023

Upcoming dividend of US$0.15 per share at 0.9% yield

First quarter 2023 earnings released: EPS: US$0.89 (vs US$0.88 in 1Q 2022)

Investor sentiment improves as stock rises 16%

Upcoming dividend of US$0.15 per share at 1.2% yield

Full year 2022 earnings released: EPS: US$2.59 (vs US$4.15 in FY 2021)

Encompass Health Corporation Provides Earnings Guidance for the Full Year 2023

Encompass Health Corporation to Report Q4, 2022 Results on Feb 07, 2023

Upcoming dividend of US$0.15 per share

High number of new directors

Independent Director recently bought €101k worth of stock

Encompass Health Corporation Revises Earnings Guidance for the Year 2022

Third quarter 2022 earnings released: EPS: US$0.64 (vs US$1.01 in 3Q 2021)

Encompass Health Corporation Declares Quarterly Cash Dividend, Payable on January 17, 2023

Encompass Health Corporation to Report Q3, 2022 Results on Oct 26, 2022

Upcoming dividend of US$0.15 per share

Second quarter 2022 earnings released: EPS: US$0.49 (vs US$1.14 in 2Q 2021)

Encompass Health Corporation Affirms Earnings Guidance for the Year 2022

Encompass Health Corporation Declares Dividend on Common Stock, Payable on October 17, 2022

Encompass Health Corporation to Report Q2, 2022 Results on Aug 01, 2022

Upcoming dividend of US$0.28 per share

Investor sentiment deteriorated over the past week

Encompass Health Corporation completed the Spin-Off of Enhabit, Inc. (NYSE:EHAB).

Encompass Health Corporation Revises Earnings Guidance for the Full Year 2022

Insider recently bought €63k worth of stock

Encompass Health Corporation Declares Quarterly Cash Dividend on Common Stock, Payable on July 20, 2022

First quarter 2022 earnings released: EPS: US$0.88 (vs US$1.08 in 1Q 2021)

Encompass Health Corporation Reaffirms Its Revenue Guidance for the Full Year 2022

Encompass Health Corporation, Annual General Meeting, May 05, 2022

Encompass Health Corporation Announces Board Changes

Upcoming dividend of US$0.28 per share

Encompass Health's Home Health Unit Reportedly Attracts Acquisition interest

Encompass Health Corporation Declares Dividend on Common Stock, Payable on April 18, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Encompass Health Corporation Provides Earnings Guidance for the Year 2022

Jana Partners Pushes Encompass Health to Pursue a Possible Merger

Upcoming dividend of US$0.28 per share

Third quarter 2021 earnings released: EPS US$1.01 (vs US$0.78 in 3Q 2020)

Upcoming dividend of US$0.28 per share